# BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)

> **NCT01520441** · EARLY_PHASE1 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Prostate Cancer
- Benign Prostatic Hyperplasia
- Enlarged Prostate With Lower Urinary Tract Symptoms (LUTS)

## Interventions

- **DRUG:** BOTOX

## Key facts

- **NCT ID:** NCT01520441
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520441, "BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01520441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*